Gynaecological Cancer Research Group, Lowy Cancer Research Centre and School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Br J Cancer. 2020 Jul;123(1):9-16. doi: 10.1038/s41416-020-0875-x. Epub 2020 May 8.
The build-up of fluid in the peritoneal cavity-ascites-is a hallmark of ovarian cancer, the most lethal of all gynaecological malignancies. This remarkable fluid, which contains a variety of cellular and acellular components, is known to contribute to patient morbidity and mortality by facilitating metastasis and contributing to chemoresistance, but remains largely under-researched. In this review, we will critically analyse the evidence associating ascites with metastasis and chemoresistance in ovarian cancer and provide an update on research in the field. We will argue the case for ascites as a unique and accessible substrate for tracking tumour progression and for translational research that will enhance our understanding of this cancer and lead to improvements in patient outcomes.
腹腔积液(腹水)的积聚是卵巢癌的一个标志,而卵巢癌是所有妇科恶性肿瘤中最致命的一种。这种特殊的液体含有各种细胞和无细胞成分,已知通过促进转移和导致化疗耐药性来导致患者的发病率和死亡率增加,但对其的研究仍远远不够。在这篇综述中,我们将批判性地分析腹水与卵巢癌转移和化疗耐药性相关的证据,并提供该领域研究的最新进展。我们将认为腹水是一种独特且易于获取的追踪肿瘤进展的基质,并为转化研究提供论据,这将增强我们对这种癌症的理解,并改善患者的治疗效果。